Home » Newsletters » BioWorld

BioWorld

March 5, 1992

View Archived Issues

NEUPOGEN SALES BEGIN IN CANADA

DYNAGEN TEST WINS MARKETING APPROVAL

COLUMBIA, INSITE EXCHANGE TECHNOLOGY

CEPHALON PATENT FOR ALS TREATMENT

ISIS ANTI-WART COMPOUND TO ENTER CLINIC

NEUROGEN LICENSES ANTI-CONVULSANT

EPA EXPANDS APPROVAL FOR CUTLASS

SCIENTISTS RETRACT ALZHEIMER'S FINDINGS

T CELL COMPOUND REDUCES TISSUE DAMAGE

TAXOL MARKETING APPLICATION THIS YEAR

ATHENA MABS BLOCK MS-LIKE PARALYSIS